12/15-lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and function

Journal of Clinical Investigation

Volumn 125, Issue 5, 2015, Pages 1944-1954

  Rothe, Tobias ^a,b   Gruber, Florian ^c   Uderhardt, Stefan ^a,b   Ipseiz, Natacha ^a,b   Rössner, Susanne ^b   Oskolkova, Olga ^d   Blüml, Stephan ^d   Leitinger, Norbert ^e   Bicker, Wolfgang ^f   Bochkov, Valery N ^d   Yamamoto, Masayuki ^g   Steinkasserer, Alexander ^b   Schett, Georg ^a   Zinser, Elisabeth ^b   Krönke, Gerhard ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Universitatsklinik fur Dermatologie   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF VIRGINIA   (United States)

^f FTC Forensic Toxicological Laboratory Ltd   (Austria)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; GLUTAMATE CYSTEINE LIGASE; HEME OXYGENASE 1; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 23P19; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR NRF2; ALOX15 PROTEIN, MOUSE; FATTY ACID; NFE2L2 PROTEIN, MOUSE; PHOSPHOLIPID;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; LIPID OXIDATION; LYMPHOCYTE DIFFERENTIATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DEFICIENCY; ENZYMOLOGY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOID TISSUE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; CELL DIFFERENTIATION; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FATTY ACIDS; FEMALE; HUMANS; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; PHOSPHOLIPIDS; TH17 CELLS;

EID: 84929000116     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI78490     Document Type: Article

References (44)

1. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage:ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31:563-604.
2. Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol. 2013;13(8):566-577.
3. Ivanov I, et al. Molecular enzymology of lipoxygenases. Arch Biochem Biophys. 2010;503(2):161-174.
4. Kühn H, Römisch I, Belkner J. The role of lipoxygenase-isoforms in atherogenesis. Mol Nutr Food Res. 2005;49(11):1014-1029.
5. Cyrus T, et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest. 1999;103(11):1597-1604.
6. Kühn H, O'Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006;45(4):334-356.
7. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation:dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349-361.
8. Serhan CN, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol. 2003;171(12):6856-6865.
9. Krönke G, et al. 12/15-lipoxygenase counteracts inflammation tissue damage in arthritis. J Immunol. 2009;183(5):3383-3389.
10. Uderhardt S, et al. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells maintains immunologic tolerance. Immunity. 2012;36(5):834-846.
11. Uderhardt S, Krönke G. 12/15-lipoxygenase during the regulation of inflammation, immunity, self-tolerance. J Mol Med (Berl). 2012;90(11):1247-1256.
12. Spanbroek R, et al. IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase up-regulation of 15-lipoxygenase 1 expression. Proc Natl Acad Sci U S A. 2001;98(9):5152-5157.
13. Shamshiev AT, Ampenberger F, Ernst B, Rohrer L, Marsland BJ, Kopf M. Dyslipidemia inhibits toll-like receptor-induced activation of CD8alpha-negative dendritic cells protective Th1 type immunity. J Exp Med. 2007;204(2):441-452.
14. Morgan AH, et al. Phosphatidylethanolamine-esterified eicosanoids in the mouse:tissue localization and inflammation-dependent formation in Th-2 disease. J Biol Chem. 2009;284(32):21185-21191.
15. Kadl A, et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res. 2010;107(6):737-746.
16. Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13(8):722-728.
17. Pierson E, Simmons SB, Castelli L, Goverman JM. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol Rev. 2012;248(1):205-215.
18. Kuhn H. Structural basis for the positional specificity of lipoxygenases. Prostaglandins Other Lipid Mediat. 2000;62(3):255-270.
19. Blüml S, et al. Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol. 2005;175(1):501-508.
20. Blüml S, et al. Epigenetic regulation of dendritic cell differentiation and function by oxidized phospholipids. Blood. 2009;114(27):5481-5489.
21. Asquith DL, Miller AM, Hueber AJ, Liew FY, Sattar N, McInnes IB. Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis. Arthritis Rheum. 2010;62(2):472-477.
22. Angeli V, et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity. 2004;21(4):561-574.
23. Cyrus T, et al. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation atherogenesis in apolipoprotein e-deficient mice. Circulation. 2001;103(18):2277-2282.
24. Berliner JA, Subbanagounder G, Leitinger N, Watson AD, Vora D. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends Cardiovasc Med. 2001;11(3-4):142-147.
25. Al-Huseini LM, et al. Nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) modulates dendritic cell immune function through regulation of p38 MAPK-cAMP-responsive element binding protein/activating transcription factor 1 signaling. J Biol Chem. 2013;288(31):22281-22288.
26. Aw Yeang HX, et al. Loss of transcription factor nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) leads to dysregulation of immune functions, redox homeostasis, intracellular signaling in dendritic cells. J Biol Chem. 2012;287(13):10556-10564.
27. Rangasamy T, et al. Nuclear erythroid 2 p45-related factor 2 inhibits the maturation of murine dendritic cells by ragweed extract. Am J Respir Cell Mol Biol. 2010;43(3):276-285.
28. Williams MA, et al. Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter. J Immunol. 2008;181(7):4545-4559.
29. Middleton MK, Rubinstein T, Puré E. Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase. J Immunol. 2006;176(1):265-274.
30. Zhao L, et al. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J Biol Chem. 2002;277(38):35350-35356.
31. Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 2004;18(11):1318-1320.
32. Emerson MR, LeVine SM. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase. Brain Res. 2004;1021(1):140-145.
33. Johnson DA, Amirahmadi S, Ward C, Fabry Z, Johnson JA. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci. 2010;114(2):237-246.
34. Pareek TK, et al. Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation promotes remyelination in autoimmune encephalomyelitis. Sci Rep. 2011;1:201.
35. Bar-Or A, et al. Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis:subgroup analyses of the DEFINE study. J Neurol. 2013;260(9):2297-2305.
36. Gold R, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med. 2012;367(12):1098-1107.
37. Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res. 2011;50(1):115-131.
38. Itoh K, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236(2):313-322.
39. Zal T, Volkmann A, Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med. 1994;180(6):2089-2099.
40. Lutz MB, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223(1):77-92.
41. Pfeiffer IA, et al. Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes. Immunobiology. 2013;218(11):1392-1401.
42. von Schlieffen E, et al. Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2009;29(3):356-362.
43. Watson AD, et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272(21):13597-13607.
44. Krönke G, et al. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem. 2003;278(51):51006-51014.